Acromesomelic dysplasia is genetically heterogeneous group of skeletal disorders characterized by short stature and acromelia and mesomelia of limbs. Acromesomelic dysplasia segregates in an autosomal recessive pattern and is caused by biallelic sequence variants in three genes (NPR2, GDF5, and BMPR1B).
INTRODUCTION
Acromesomelic dysplasia is a group of hereditary skeletal disorders characterized by abnormal growth of bones, cartilages, and connective tissues. It is further classified into five subgroups, namely acromesomelic dysplasia Maroteaux type (AMDM, MIM 602875), acromesomelic dysplasia Grebe type (AMDG, MIM 200700) , acromesomelic dysplasia Hunter-Thompson type (AMDH, MIM 201250), acromesomelic dysplasia DuPan type (AMDDu, MIM 228900), and acromesomelic dysplasia Demirhan type (AMDD, MIM 609441) (Bonafe et al., 2015; Warman, Cormier-Daire, & Hall, 2011) .
Acromesomelic dysplasia Maroteaux type is characterized by short stature and shortening of the middle and distal segments of the appendicular and axial skeleton. This is caused by biallelic sequence variants in the natriuretic peptide receptor-2 (NPR2) (Bartels et al., 2004; Irfanullah, Umair, Khan, & Ahmad, 2015; Khan et al., 2012) .
Acromesomelic dysplasia Grebe type is characterized by short stature and abnormalities confined to the limbs, namely toe-like fingers, fusion or absence of carpals and tarsals, and missing joints. Biallelic sequence variants in the growth and differentiation factor 5 (GDF5) or its receptor bone morphogenetic protein receptor-1b (BMPR1B) cause AMDG (Basit et al., 2008; Graul-Neumann et al., 2014; Khan, Basit, Khan, Muhammad, & Ahmad, 2016; Thomas et al., 1996; Umair et al., 2016) .
Acromesomelic dysplasia Hunter-Thompson type is characterized by shortening of the limbs. Lower limbs are more affected than the upper limbs. Lower limb anomalies include short femurs, tibias, and fibulas as well as dislocated ankles, and those of the upper limbs include hands with short phalanges and metacarpals, short humerus, and a curved radius and ulna. The middle and distal limbs are most affected. AMDH is caused by biallelic variants in the GDF5 (Thomas et al., 1996) .
Acromesomelic dysplasia DuPan type, also known as fibular hypoplasia and complex brachydactyly, is characterized by mild shortening of the limbs. Affected individuals have normal radius, ulna, femur, carpals, metacarpals, and phalanges. Tarsals, metatarsals, and phalanges of toes are mildly affected with impalpable fibulae. This type of acromesomelic dysplasia is caused by biallelic variants in the GDF5 and BMPR1B genes (Stange et al., 2015) .
In AMDD, limb shortening is associated with genital anomalies, namely hypoplasia of the uterus and premature ovarian failure leading to hypogonadotropic hypogonadism. Demirhan et al. (2005) reported on an 8 bp deletion (c.361_368del8) in BMPR1B causing AMDD in a Turkish family. AMDD differs from AMDG because of the presence of genital anomalies and the distinct limb phenotype.
Here, we present a consanguineous Pakistani family from the Sindh province with four members affected with AMDH caused by a homozygous sequence variant in the BMPR1B gene.
MATERIALS AND METHODS
The present study was approved by the institutional review board of Quaid-i-Azam University Islamabad, Pakistan. Informed consent was obtained from all family members who participated in the study. Blood samples from four affected (IV-8, V-1, V-3, and V-4) and three unaffected members (IV-2, IV-4, and IV-6) of the family were collected in ethylenediaminetetraacetic acid tubes (BD, Franklin Lakes, NJ, USA). Genomic DNA was extracted using the Sigma-Aldrich GenElute Blood Genomic DNA Kit (St. Louis, MO, USA).
Genotyping and analysis
Genotyping was performed using microsatellite markers flanking NPR2 on chromosome 9p12-21 and BMPR1B on chromosome 4q22.3. PCR-based genotyping was carried out as previously described (Ullah et al., 2015) . PCR products were resolved on 8% nondenaturing polyacrylamide gel and analyzed after staining with ethidium bromide. The haplotype was constructed using 10 microsatellite markers (D4S2929, D4S2460, D4S2461, D4S3245, D4S3006, D4S423, D4S2364, D4S2433, D4S2909, and D4S1560) linked to BMPR1B (Fig. 1a) . Two-point and multipoint linkage analyses was performed using Superlink (Silberstein et al., 2006) assuming an autosomal-recessive mode of inheritance with no reduced penetrance or phenocopies. Because of the rarity of AMDH, a disease frequency of 0.00001 was used in the analysis. Equal allele frequencies were used for each marker. Two-point linkage analysis was also performed for the identified variant, assuming an allele frequency of 0.0000001 for the alternative allele since the variant was not observed in gnomAD.
Sequencing GDF5 and BMPR1B
Sequences of GDF5 and BMPR1B were downloaded from Ensembl genome browser (https://asia.ensembl.org/index. html) and primers for the coding exons and splice sites were designed for the intronic regions using Primer3 software (https://bioinfo.ut.ee/primer3-0.4.0/primer3/) (Untergasser et al., 2012) . The primer sequences are available on request. PCR products were analyzed on 2% agarose gel and purified using a commercially available kit (Axygen Inc., CA, USA). DNA sequencing was performed using DTCS Quick Start sequencing kit (Beckman Coulter, Fullerton, CA, USA). Sequencing results were aligned through BIOEDIT sequence alignment editor version 6.0.7 (Ibis Biosciences, Carlsbad, CA, USA). Pathogenitcity and the impact of the variant on the protein function of the identified variant was analyzed using MutationTaster (https://www.mutationtaster.org/index.html) and Polymorphism Phenotyping v2 (PolyPhen-2) (https:// genetics.bwh.harvard.edu/pph2/), respectively.
RESULTS
All four affected members of the family presented clinical features of AMDH. At the time of this study, the ages of the affected pedigree members were between 24 and 30 years, and their height ranged from 140 to 141 cm. They displayed a severe form of short stature with abnormalities limited to an appendicular skeleton. Anomalies observed included short radii/ulnae, shorts and bowed tibias/fibulas, and short fingers and toes. The axial and craniofacial skeleton were not affected. Detailed clinical and radiological features, recorded in two affected members (V-1 and V-4) compared to an unaffected population of same ethnicity group, are presented in Figure 2b -i (Table 1) . Endocrinological studies in two affected members (V-1 and V-4) revealed normal levels of gonadotropins, particularly luteinizing hormone and folliclestimulating hormone. The two affected females (IV-8 and V-3) declined to provide photographs for presentation in publications. Affected members were able to work in an adequate manner despite having limb anomalies.
Genotyping and sequence analysis
Biallelic variants in the GDF5 gene have been reported to cause AMDH; therefore, coding regions of the gene were Sanger sequenced in all four affected members of the family. However, analysis of the sequences failed to detect any variants in the GDF5 gene. Genotyping using microsatellite markers linked to BMPR1B (D4S2929, D4S2460, D4S2451, D4S3245, D4S3006, D4S423, D4S2364, D4S2433, D4S2909, and D4S1560) and NPR2 (D9S1118, D9S1788, D9S1817, D9S761, D9S1794, D9S50, D9S772, and D9S55) was then performed using DNA samples from all available affected and unaffected family members. Haplotype analysis revealed a 7.78 Mb homozygous region among affected members on chromosome 4q22.3, which harbors BMPR1B (Fig. 1a) . Microsatellite markers linked to NPR2 were heterozygous in both affected and unaffected individuals, suggesting an absence of linkage to chromosome 9p12-21. No recombination events were observed with markers D4S2461, D4S3245, D4S3006, D4S423, D4S2364, D4S2433, and D4S2909, and they each produced a logarithm of odds (LOD) score of 1.5 at theta = 0. Multipoint linkage analysis produced a maximum LOD score of 2.7. Sequence analysis revealed a homozygous missense variant (c.1190T > G, p.Met397Arg) in exon 9 of the BMPR1B gene in affected family members (Fig. 2a) . Further sequencing using DNA samples from unaffected members validated segregation of the variant with disease phenotype in the family (Fig. 2c-e) . Two-point linkage analysis performed between the disease phenotype and c.1190T > G variant produced an LOD score of 3.9 at theta = 0. The mutation effect prediction tool MutationTaster predicted the substitution of methionine at amino acid position 397 with arginine as disease causing. PolyPhen-2 predicted that the substitution (p.Met397Arg), present in the kinase domain of the BMPR1B gene, has a damaging effect on protein structure and function. Clustal Omega analysis showed that the methionine at position 397 of the BMPR1B gene is completely conserved among all species known to have a BMPR1B ortholog (Fig. 2f) . The identified variant was not found in available databases of genetic variations (i.e. dbSNP, EVS, and gnomAD) or in the 200 ethnically matched control individuals of Pakistani origin sequenced in the present study.
DISCUSSION
Three different types of acromesomelic dysplasia, namely Grebe, DuPan and Hunter-Thompson, are characterized by shortening of the appendicular skeleton, which segregate in an autosomal-recessive pattern. Short stature with abnormalities limited to limbs, with lower limbs more affected than the upper limbs, are the key features of AMDH. Feet are very short, often bowed with short great toes forcing affected individuals to walk on knees. Some toes are ball-shaped and functionless. The proximal and middle phalanges are either short or absent; however, distal phalanges are normal in both hands (Faivre & Cormier-Daire, 2005; Thomas et al., 1996) . Toe-like fingers and proportionate involvement of the upper and lower limbs differentiate AMDG from AMDDu and AMDH. Similarly, mild short stature and milder limb defects in AMDDu, namely fibular hypoplasia and complex brachydactyly, differentiate it from AMDH (Stange et al., 2015) .
Affected individuals in the family, presented here, showed phenotypes of AMDH. Patients have short but functional toes with the ability to walk on their feet. Shortening of the limbs was limited to the medial and distal parts. Shortening of hands, metacarpals and distal phalanges, forearms with bowed radius, and feet and forelegs with bowed tibias/fibulas were observed in all of the patients. The observed phenotypes were consistent for all affected family members. Normal levels of luteinizing hormone and follicle-stimulating hormone, short fingers, and a normal axial skeleton support the diagnosis of AMDH in the family.
Acromesomelic dysplasia types Grebe and DuPan are caused by biallelic sequence variants in the GDF5 gene and its receptor coding gene BMPR1B. Biallelic sequence variants in the GDF5 gene also cause AMDH. However, variants in the BMPR1B gene causing AMDH have not been reported previously. To the best of our knowledge, our study reported the first familial case of AMDH caused by a homozygous sequence variant in the BMPR1B gene. Genotyping using microsatellite markers followed by Sanger sequencing of BMPR1B revealed a homozygous missense variant (p.Met397Arg) in all the affected members of the family.
GDF5 belongs to bone morphogenetic protein (BMP) family and the transforming growth factor-β (TGF-β) superfamily. BMPs are multifunctional proteins regulating cell growth, differentiation and apoptosis. GDF5 is a ligand for BMP receptors type 1 and 2. Binding of GDF5 to its receptor activates BMPR1B by trans-phosphorylation through BMPR2. Activated BMPR1B phosphorylates receptor-regulated SMADs, namely Smad1, Smad5, and Smad8. These then interact with Smad4 (common-mediator Smad) and translocate into the nucleus to regulate transcription of the target genes (Derynck, Zhang, & Feng, 1998; Massague & Wotton et al., 2000) . BMP receptors also activate p38 MAPK and JNK pathways (Heldin, Miyazono, & ten Dijke, 1997) . These signal cascades regulate transcription of specific target genes, which are involved in bone formation (Gilboa et al., 2000; von Bubnoff & Cho, 2011) . Biallelic sequence variants in either GDF5 or BMPR1B can cause considerable phenotypic variations of acromesomelic dysplasia, and the latter seem to represent a severity continuum with mutation in either of these two genes encoding a ligand-receptor pair.
To date, four sequence variants in the BMPR1B gene causing acromesomelic dysplasia have been reported (Table 2) . The sequence variant (p.Met397Arg), identified in our family, is located in serine-threonine kinase domain of BMPR1B (Fig. 2a-b (p.Met397Arg) is located in the kinase domain, which most likely leads to impairment of BMPR1B's ability to phosphorylate Smads. A homozygous nonsense variant (p.Trp219*) in the same domain, in a family of Pakistani origin reported by Graul-Neumann et al. (2014) , caused more severe form of acromesomelic dysplasia, AMDG. It is highly likely that the nonsense variant in the kinase domain results in complete loss of function of protein through nonsense-mediated mRNA decay and/or protein truncation.
In the present study, we believe that we have presented evidence of the first familial case of AMDH caused by a sequence variant in the BMPR1B gene.
